I am sure TIND is real, but I am wondering why the German guidelines of diabetes treatment seem to ignore the facts and allow freshly diagnosed patients with high Hb1Ac to reduce their blood glucose fast and risk pain, suffering and, possibly, induce severe complications of too fast reductions of blood glucose. How is it in other countries, are there more modern recommendations?
short report: http://www.neurologytimes.com/diabetes/treatment-induced-neuropathy-diabetes-underrecognized-rise/page/0/1
Hi
South African Guidelines also don't address this entity, even though it is well described by clinicians.
Perhaps we need more research into successful management strategies? Do you know of any?
Most clinicians will try to reduce the rate of reduction of HbA1C, if the HbA1C is high at baseline assessment. [or the patient will reduce their medication....]
But we need more clinical trials to guide us, with the details.
- Badges
- Science topic
- Similar topics
- Medicine
- Disease
- Metabolic Diseases
- Glucose Metabolism Disorders
- Diabetes